Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

MEI Pharma Company Profile (NASDAQ:MEIP)

Consensus Ratings for MEI Pharma (NASDAQ:MEIP) (?)
Ratings Breakdown: 3 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 3.25)
Consensus Price Target: $16.00 (104.08% upside)

Analysts' Ratings History for MEI Pharma (NASDAQ:MEIP)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/16/2014Roth CapitalBoost Price TargetFocus List$20.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
9/8/2014Cantor FitzgeraldInitiated CoverageBuy$14.00ViewTweet This Rating  Share This Rating on StockTwits
7/8/2014Brean CapitalInitiated CoverageBuy$16.00ViewTweet This Rating  Share This Rating on StockTwits
1/10/2014Brean CapitalInitiated CoverageBuy$16.00ViewTweet This Rating  Share This Rating on StockTwits
12/5/2013WedbushInitiated CoverageOutperform$12.00ViewTweet This Rating  Share This Rating on StockTwits
10/22/2013Stifel NicolausBoost Price TargetBuy$11.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
10/21/2013Roth CapitalBoost Price TargetBuy$16.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
5/24/2013Cowen and CompanyInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
4/15/2013Stifel NicolausInitiated CoverageBuy$11.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/25/2012 forward)
Discuss MEI Pharma